CD8A and erythema multiforme: The risk of hypersensitivity drug reactions increases when the CD4+:CD8 + T-cell ratio is low, leading to the hyperactivation of CD8 + T-cells, which is important in delayed hypersensitivity reactions involved in the pathogenesis of EM [10, 16, 24].